Skip to main content
Log in

Benign Gastric Polyps: Morphological and Functional Origin

  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

The most common types of benign gastric polyps are fundic gland polyps, hyperplastic polyps, and adenomas. The aim of this study was to determine on which morphological and functional background benign gastric polyps develop. The study includes 85 consecutive patients with gastric polyps and sex- and age-matched controls without polyps selected at random from a general population sample. The type of polyp was hyperplastic in 52 (61%), fundic gland in 18 (21%), adenoma in 10 (12%), carcinoid in 2 (2%), hamartoma in 2 (2%), and inflammatory fibroid in 1 (1%) of the cases. Routine biopsies from the gastric corpus and antrum were examined for presence of gastritis and H. pylori. Blood samples were analyzed for H. pylori antibodies, H+,K+-ATPase antibodies, gastrin, and pepsinogen I. Patients with hyperplastic polyps had increased P-gastrin concentrations and S-H+,K+-ATPase antibody titers and decreased S-pepsinogen I concentrations with a high prevalence of atrophic corpus gastritis or pangastritis. A similar pattern was observed among patients with adenomas, whereas patients with fundic gland polyps had normal serology and a lower prevalence of gastritis and H. pylori infection than controls. In conclusion, hyperplastic polyps and adenomas are generally associated with atrophic gastritis. Patients with fundic gland polyps seem to have a sounder mucosa than controls. Whereas the risk of malignant gastric neoplasia is increased in patients with hyperplastic polyps or adenomas, this does not seem to be the case in patients with fundic gland polyps.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Rosen S, Hoak D: Intramucosal carcinoma developing in a hyperplastic gastric polyp. Gastrointest Endosec 39:830-832, 1993

    Google Scholar 

  2. Stolte M, Sticht T, Eidt S, Ebert D, Finkenzeller G: Frequency, location and age and sex distribution of various types of gastric polyps. Endoscopy 26:659-665, 1994

    Google Scholar 

  3. Stolte M: Clinical consequences of the endoscopic diagnosis of gastric polyps. Endoscopy 27:32-37, 1995

    Google Scholar 

  4. WHO Classification of Tumours. Pathology and Genetics: Tumours of the Digestive System. IARC Press, Lyon, France, 2000

    Google Scholar 

  5. Ming S, Goldman H: Gastric polyps. A histogenetic classification and its relation to carcinoma. Cancer 18:721-726, 1965

    Google Scholar 

  6. Elster K: Histologic classification of gastric polyps. Curr Top Pathol 63:77-93, 1976

    Google Scholar 

  7. Daibo M, Itabashi M, Hirota T: Malignant transformation of gastric hyperplastic polyps. Am J Gastroenterol 82:1016-1025, 1987

    Google Scholar 

  8. Järvinen HJ: Other gastrointestinal polyps. World J Surg 15:50-56, 1991

    Google Scholar 

  9. Cristallini E, Ascani S, Bolis G. Association between histologic type of polyp and carcinoma in the stomach. Gastrointest Endosc 38:481-484, 1992

    Google Scholar 

  10. Hizawa K, Fuchigami T, Iida M, Aoyagi K, Iwashita A, Daimaru Y, Fujishima M: Possible neoplastic transformation within gastric hyperplastic polyp. Surg Endosc 9:714-718, 1995

    Google Scholar 

  11. Orlowska J, Jarosz D, Pachlewski J, Butruk E: Malignant transformation of benign epithelial gastric polyps. Am J Gastroenterol 90:2152-2159, 1995

    Google Scholar 

  12. Papa A, Cammarota G, Tursi A, Montalto M, Cuoco L, Certo M, et al: Histologic types and surveillance of gastric polyps: a seven year clinico-pathological study. Hepato-Gastroenterol 45:579-582, 1998

    Google Scholar 

  13. Rattan J, Arber N, Tiomny E, Moshkowitz M, Chapsky Y, Baratz M, et al: Gastric polypoid lesions—an eight year study. Hepatogastroenterol 40:107-109, 1993

    Google Scholar 

  14. Haruma K, Sumii K, Yoshihara M, Watanabe C, Kajiyama G: Gastric mucosa in female patients with fundic glandular polyps. J Clin Gastroenterol 13:565-569, 1991

    Google Scholar 

  15. Haruma K, Yoshihara M, Sumii K, Tari A, Watanabe C, Kodoi A, et al: Gastric acid secretion, serum pepsinogen I, and serum gastrin in Japanese with gastric hyperplastic polyps or polypoid-type early gastric carcinoma. Scand J Gastroenterol 28:633-637, 1993

    Google Scholar 

  16. Laxen F, Kekki M, Sipponen P, Siurala M: The gastric mucosa in stomachs with polyps: morphologic and dynamic evaluation. Scand J Gastroenterol 18:503-511, 1983

    Google Scholar 

  17. Nakano H, Persson B, Slezak P: Study of the gastric mucosal background in patients with gastric polyps. Gastrointest Endosc 36:39-42, 1990

    Google Scholar 

  18. Sakai N, Tatsuta M, Hirasawa R, Iishi H, Baba M, Yokota Y, et al: Low prevalence of Helicobacter pylori infection in patients with hamartomatous fundic polyps. Dig Dis Sci 43:766-772, 1998

    Google Scholar 

  19. Borch K, Renvall H, Liedberg G: Gastric endocrine cell hyperplasia and carcinoid tumors in pernicious anemia. Gastroenterology 88:638-648, 1985

    Google Scholar 

  20. Carneiro F, David L, Seruca R, Castedo S, Nesland JM, Sobrinho-Simoes M: Hyperplastic polyposis and diffuse carcinoma of the stomach. A study of a family. Cancer 72:323-329, 1993

    Google Scholar 

  21. Orlowska J, Pietrow D. Multifocal gastric carcinoma arising from hyperplastic and adenomatous polyps. Am J Gastroenterol 85:1629-1634, 1990

    Google Scholar 

  22. Harju E: Gastric polyposis and malignancy. Br J Surg 73:532-533, 1986

    Google Scholar 

  23. Dickey W, Kenny BD, McConnell JB: Prevalence of fundic gland polyps in a western European population. J Clin Gastroenterol 23:73-75, 1996

    Google Scholar 

  24. Iida M, Yao T, Itoh H, Watanabe H, Kohrogi N, Shigematsu A, et al: Natural history of fundic gland polyposis in patients with familial adenomatosis coli/Gardner's syndrome. Gastroenterology 89:1021-1025, 1985

    Google Scholar 

  25. Kinoshita Y, Tojo M, Yano T, Kitajima N, Itoh T, Nishiyama K, et al: Incidence of fundic gland polyps in patients without familial adenomatous polyposis. Gastointest Endosc 39:161-163, 1993

    Google Scholar 

  26. Marcial MA, Villafana M, Hernandez-Denton J, Colon-Pagan JR: Fundic gland polyps: prevalence and clinicopathologic features. Am J Gastroenterol 88:1711-1713, 1993

    Google Scholar 

  27. El-Zimaity HMT, Jackson FW, Graham DY: Fundic gland polyps developing during omeprazole therapy. Am J Gastroenterol 92:1858-1860, 1997

    Google Scholar 

  28. Ginsberg GG, Al-Kawas FH, Fleischer DE, Reilly HF, Benjamin SB: Gastric polyps: relationship of size and histology to cancer risk. Am J gastroenterol 91:714-717, 1996

    Google Scholar 

  29. Yoshihara M, Sumii K, Haruma K, Kiyohira K, Hattori N, Kitadai Y, et al: Correlation of ratio of serum pepsinogen I and II with prevalence of gastric cancer and adenoma in Japanese subjects. Am J Gastroenterol 93:1090-1096, 1998

    Google Scholar 

  30. King RM, van Heerden JA, Weiland LH: The management of gastric polyps. Surg Gynecol Obstet 155:846-848, 1982

    Google Scholar 

  31. Borch K, Renvall H, Liedberg G, Andersen BN: Relations between circulating gastrin and endocrine cell proliferation in the atrophic gastric fundic mucosa. Scand J Gastroenterol 21:357-363, 1986

    Google Scholar 

  32. Hallissey MT, Dunn JA, Fielding JWL: Evaluation of pepsinogen I and gastrin-17 as markers of gastric cancer and high-risk pathologic conditions. Scand J Gastroenterol 29:1129-1134, 1994

    Google Scholar 

  33. Westerveld BD, Pals G, Lamers CB, Defize J, Pronk JC, Frants RR, Meuwissen SGM, et al: Clinical significance of pepsinogen A isozymogens, serum pepsinogen A and C levels; and serum gastrin levels. Cancer 59:952-958, 1987

    Google Scholar 

  34. Toh BH, van Driel IR, Gleeson PA: Pernicious anemia. N Engl J Med 13:1441-1448, 1997

    Google Scholar 

  35. Varis O, Laxen F, Valle J: Helicobacter pylori infection and fasting serum gastrin levels in a series of endoscopically diagnosed gastric polyps. APMIS 102:759-764

  36. Borch K, Kullman E, Hallhagen S, Ledin T, Ihse I: Increased incidence of pancreatic neopiasia in pernicious anemia. World J Surg 12:866-870, 1988

    Google Scholar 

  37. Borch K: Atrophic gastritis and carcinoid tumours. Ann Med 21:291-297, 1989

    Google Scholar 

  38. Sipponen P, Kekki M, Haapakoski J, Ihamäki T, Siurala M: Gastric cancer risk in chronic atrophic gastritis: statistical calculations of cross-sectional data. Int J Cancer 35:173-177, 1985

    Google Scholar 

  39. Veereman Wauters G, Ferrell L, Ostroff JW, Heyman MB: Hyperplastic gastric polyps associated with persistent Helicobacter pylori infection and active gastritis. Am J Gastroenterol 85:1395-1397, 1990

    Google Scholar 

  40. Dixon MF, Genta RM, Yardley JH, Correa P: Classification and grading of gastritis. The updated Sydney system. Am J Surg Pathol 20:1161-1181, 1996

    Google Scholar 

  41. Ma JY, Borch K, Sjöstrand SE, Janzon L, Mårdh S: Positive correlation between H,K-adenosine triphosphatase autoantibodies and Helicobacter pylori antibodies in patients with pernicious anemia. Scand J Gastroenterol 29:961-965, 1994

    Google Scholar 

  42. Rehfeld JF, Stadil F, Rubin B: Production and evaluation of antibodies for the radioimmunoassay of gastrin. Scand J Clin Lab Invest 30:221-232, 1972

    Google Scholar 

  43. Rehfeld JF: Sequence-specific radioimmunoassays for gastrin, cholecystokinin and somatostatin. Biomed Res 1:73-78

  44. Borch K, Jansson K-, Petersson F, Rede n S, M rdh S, Franz n LE: Prevalence of gastroduodenitis and Helicobacter pylori infection in a general population sample: Relations to symptomatology and life style. Dig Dis Sci 45:1322-1329, 2000

    Google Scholar 

  45. Samloff IM, Varis K, Ihamäki T, Siurala M, Rotter JI: Relationships among serum pepsinogen I, serum pepsinogen II, and gastric mucosal histology—a study in relatives of patients with pernicious anemia. Gastroenterol 83:204-209, 1982

    Google Scholar 

  46. Borch K, Axelsson CK, Halgreen H, Damkjaer-Nielsen MD, Ledin T, Szesci PB: The ratio of pepsinogen I to pepsinogen C: A sensitive test for atrophic gastritis. Scand J Gastroenterol 24:870-876, 1989

    Google Scholar 

  47. Valle J, Kekki M, Sipponen P, Ihamäki T, Siurala M: Long-term course and sonsequences of Helicobacter pylori gastritis. Results of a 32-year follow-up study. Scand J Gastroenterol 31:546-550, 1996

    Google Scholar 

  48. Howden CW: Clinical expression of Helicobacter pylori infection. Am J Med 100:27S-34S, 1996

    Google Scholar 

  49. McFarlane GA, Munro A: Helicobacter pylori and gastric cancer. Br J Surg 84:1190-1199, 1997

    Google Scholar 

  50. Zwick A, Munir M, Ryan CK, Gian J, Burt RW, Leppert M, et al: Gastric adenocarcinoma and dysplasia in fundic gland polyps of a patient with attenuated adenomatous polyposis coli. Gastroenterology 113:659-663, 1997

    Google Scholar 

Download references

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Borch, K., Skarsgård, J., Franzén, L. et al. Benign Gastric Polyps: Morphological and Functional Origin. Dig Dis Sci 48, 1292–1297 (2003). https://doi.org/10.1023/A:1024150924457

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1024150924457

Navigation